|
|
|
Volumn 22, Issue 1, 2008, Pages 87-88
|
|
European Commission approves Atripla.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADENINE;
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
BENZOXAZINE DERIVATIVE;
DEOXYCYTIDINE;
DRUG DERIVATIVE;
EFAVIRENZ;
EFAVIRENZ PLUS EMTRICITABINE PLUS TENOFOVIR DISOPROXIL;
EMTRICITABINE;
OXAZINE DERIVATIVE;
PHOSPHONIC ACID DERIVATIVE;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
TENOFOVIR;
ADULT;
DRUG APPROVAL;
DRUG COMBINATION;
EUROPEAN UNION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LEGAL ASPECT;
NOTE;
ADENINE;
ADULT;
ANTI-HIV AGENTS;
BENZOXAZINES;
DEOXYCYTIDINE;
DRUG APPROVAL;
DRUG COMBINATIONS;
EUROPEAN UNION;
HIV INFECTIONS;
HUMANS;
OXAZINES;
PHOSPHONIC ACIDS;
REVERSE TRANSCRIPTASE INHIBITORS;
|
|
EID: 45549091071
PISSN: None
EISSN: 15577449
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (1)
|
|
References (0)
|